▶ 調査レポート

世界の臨床試験におけるCRO市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global CRO in Clinical Trials Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の臨床試験におけるCRO市場規模・現状・予測(2021年-2027年) / Global CRO in Clinical Trials Market Size, Status and Forecast 2021-2027 / QFJ1-4069資料のイメージです。• レポートコード:QFJ1-4069
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、臨床試験におけるCROの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(第I相試験、第II相試験、第III相試験、第IV相試験)、用途別市場規模(製薬業、バイオファーム)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・臨床試験におけるCROの市場動向
・企業の競争状況、市場シェア
・臨床試験におけるCROの種類別市場規模と予測2016-2027(第I相試験、第II相試験、第III相試験、第IV相試験)
・臨床試験におけるCROの用途別市場規模と予測2016-2027(製薬業、バイオファーム)
・臨床試験におけるCROの北米市場規模2016-2027(アメリカ、カナダ)
・臨床試験におけるCROの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・臨床試験におけるCROのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・臨床試験におけるCROの中南米市場規模2016-2027(メキシコ、ブラジル)
・臨床試験におけるCROの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Covance (Lab. Corp.)、QVIA、Syneos Health、Parexel、PRA Health Sciences、PPD、Charles River、ICON、Wuxi AppTec、MedPace)
・結論

Market Analysis and Insights: Global CRO in Clinical Trials Market
The global CRO in Clinical Trials market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CRO in Clinical Trials market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CRO in Clinical Trials market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CRO in Clinical Trials market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CRO in Clinical Trials market.

Global CRO in Clinical Trials Scope and Market Size
CRO in Clinical Trials market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CRO in Clinical Trials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Phase I Trial
Phase II Trial
Phase III Trial
Phase IV Trial

Segment by Application
Pharmaceutical
Bio-pharm

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Covance (Lab. Corp.)
QVIA
Syneos Health
Parexel
PRA Health Sciences
PPD
Charles River
ICON
Wuxi AppTec
MedPace

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRO in Clinical Trials Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Phase I Trial
1.2.3 Phase II Trial
1.2.4 Phase III Trial
1.2.5 Phase IV Trial
1.3 Market by Application
1.3.1 Global CRO in Clinical Trials Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical
1.3.3 Bio-pharm
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global CRO in Clinical Trials Market Perspective (2016-2027)
2.2 CRO in Clinical Trials Growth Trends by Regions
2.2.1 CRO in Clinical Trials Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 CRO in Clinical Trials Historic Market Share by Regions (2016-2021)
2.2.3 CRO in Clinical Trials Forecasted Market Size by Regions (2022-2027)
2.3 CRO in Clinical Trials Industry Dynamic
2.3.1 CRO in Clinical Trials Market Trends
2.3.2 CRO in Clinical Trials Market Drivers
2.3.3 CRO in Clinical Trials Market Challenges
2.3.4 CRO in Clinical Trials Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top CRO in Clinical Trials Players by Revenue
3.1.1 Global Top CRO in Clinical Trials Players by Revenue (2016-2021)
3.1.2 Global CRO in Clinical Trials Revenue Market Share by Players (2016-2021)
3.2 Global CRO in Clinical Trials Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CRO in Clinical Trials Revenue
3.4 Global CRO in Clinical Trials Market Concentration Ratio
3.4.1 Global CRO in Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRO in Clinical Trials Revenue in 2020
3.5 CRO in Clinical Trials Key Players Head office and Area Served
3.6 Key Players CRO in Clinical Trials Product Solution and Service
3.7 Date of Enter into CRO in Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans

4 CRO in Clinical Trials Breakdown Data by Type
4.1 Global CRO in Clinical Trials Historic Market Size by Type (2016-2021)
4.2 Global CRO in Clinical Trials Forecasted Market Size by Type (2022-2027)

5 CRO in Clinical Trials Breakdown Data by Application
5.1 Global CRO in Clinical Trials Historic Market Size by Application (2016-2021)
5.2 Global CRO in Clinical Trials Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America CRO in Clinical Trials Market Size (2016-2027)
6.2 North America CRO in Clinical Trials Market Size by Type
6.2.1 North America CRO in Clinical Trials Market Size by Type (2016-2021)
6.2.2 North America CRO in Clinical Trials Market Size by Type (2022-2027)
6.2.3 North America CRO in Clinical Trials Market Size by Type (2016-2027)
6.3 North America CRO in Clinical Trials Market Size by Application
6.3.1 North America CRO in Clinical Trials Market Size by Application (2016-2021)
6.3.2 North America CRO in Clinical Trials Market Size by Application (2022-2027)
6.3.3 North America CRO in Clinical Trials Market Size by Application (2016-2027)
6.4 North America CRO in Clinical Trials Market Size by Country
6.4.1 North America CRO in Clinical Trials Market Size by Country (2016-2021)
6.4.2 North America CRO in Clinical Trials Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe CRO in Clinical Trials Market Size (2016-2027)
7.2 Europe CRO in Clinical Trials Market Size by Type
7.2.1 Europe CRO in Clinical Trials Market Size by Type (2016-2021)
7.2.2 Europe CRO in Clinical Trials Market Size by Type (2022-2027)
7.2.3 Europe CRO in Clinical Trials Market Size by Type (2016-2027)
7.3 Europe CRO in Clinical Trials Market Size by Application
7.3.1 Europe CRO in Clinical Trials Market Size by Application (2016-2021)
7.3.2 Europe CRO in Clinical Trials Market Size by Application (2022-2027)
7.3.3 Europe CRO in Clinical Trials Market Size by Application (2016-2027)
7.4 Europe CRO in Clinical Trials Market Size by Country
7.4.1 Europe CRO in Clinical Trials Market Size by Country (2016-2021)
7.4.2 Europe CRO in Clinical Trials Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific CRO in Clinical Trials Market Size (2016-2027)
8.2 Asia-Pacific CRO in Clinical Trials Market Size by Type
8.2.1 Asia-Pacific CRO in Clinical Trials Market Size by Type (2016-2021)
8.2.2 Asia-Pacific CRO in Clinical Trials Market Size by Type (2022-2027)
8.2.3 Asia-Pacific CRO in Clinical Trials Market Size by Type (2016-2027)
8.3 Asia-Pacific CRO in Clinical Trials Market Size by Application
8.3.1 Asia-Pacific CRO in Clinical Trials Market Size by Application (2016-2021)
8.3.2 Asia-Pacific CRO in Clinical Trials Market Size by Application (2022-2027)
8.3.3 Asia-Pacific CRO in Clinical Trials Market Size by Application (2016-2027)
8.4 Asia-Pacific CRO in Clinical Trials Market Size by Region
8.4.1 Asia-Pacific CRO in Clinical Trials Market Size by Region (2016-2021)
8.4.2 Asia-Pacific CRO in Clinical Trials Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America CRO in Clinical Trials Market Size (2016-2027)
9.2 Latin America CRO in Clinical Trials Market Size by Type
9.2.1 Latin America CRO in Clinical Trials Market Size by Type (2016-2021)
9.2.2 Latin America CRO in Clinical Trials Market Size by Type (2022-2027)
9.2.3 Latin America CRO in Clinical Trials Market Size by Type (2016-2027)
9.3 Latin America CRO in Clinical Trials Market Size by Application
9.3.1 Latin America CRO in Clinical Trials Market Size by Application (2016-2021)
9.3.2 Latin America CRO in Clinical Trials Market Size by Application (2022-2027)
9.3.3 Latin America CRO in Clinical Trials Market Size by Application (2016-2027)
9.4 Latin America CRO in Clinical Trials Market Size by Country
9.4.1 Latin America CRO in Clinical Trials Market Size by Country (2016-2021)
9.4.2 Latin America CRO in Clinical Trials Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa CRO in Clinical Trials Market Size (2016-2027)
10.2 Middle East & Africa CRO in Clinical Trials Market Size by Type
10.2.1 Middle East & Africa CRO in Clinical Trials Market Size by Type (2016-2021)
10.2.2 Middle East & Africa CRO in Clinical Trials Market Size by Type (2022-2027)
10.2.3 Middle East & Africa CRO in Clinical Trials Market Size by Type (2016-2027)
10.3 Middle East & Africa CRO in Clinical Trials Market Size by Application
10.3.1 Middle East & Africa CRO in Clinical Trials Market Size by Application (2016-2021)
10.3.2 Middle East & Africa CRO in Clinical Trials Market Size by Application (2022-2027)
10.3.3 Middle East & Africa CRO in Clinical Trials Market Size by Application (2016-2027)
10.4 Middle East & Africa CRO in Clinical Trials Market Size by Country
10.4.1 Middle East & Africa CRO in Clinical Trials Market Size by Country (2016-2021)
10.4.2 Middle East & Africa CRO in Clinical Trials Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Covance (Lab. Corp.)
11.1.1 Covance (Lab. Corp.) Company Details
11.1.2 Covance (Lab. Corp.) Business Overview
11.1.3 Covance (Lab. Corp.) CRO in Clinical Trials Introduction
11.1.4 Covance (Lab. Corp.) Revenue in CRO in Clinical Trials Business (2016-2021)
11.1.5 Covance (Lab. Corp.) Recent Development
11.2 QVIA
11.2.1 QVIA Company Details
11.2.2 QVIA Business Overview
11.2.3 QVIA CRO in Clinical Trials Introduction
11.2.4 QVIA Revenue in CRO in Clinical Trials Business (2016-2021)
11.2.5 QVIA Recent Development
11.3 Syneos Health
11.3.1 Syneos Health Company Details
11.3.2 Syneos Health Business Overview
11.3.3 Syneos Health CRO in Clinical Trials Introduction
11.3.4 Syneos Health Revenue in CRO in Clinical Trials Business (2016-2021)
11.3.5 Syneos Health Recent Development
11.4 Parexel
11.4.1 Parexel Company Details
11.4.2 Parexel Business Overview
11.4.3 Parexel CRO in Clinical Trials Introduction
11.4.4 Parexel Revenue in CRO in Clinical Trials Business (2016-2021)
11.4.5 Parexel Recent Development
11.5 PRA Health Sciences
11.5.1 PRA Health Sciences Company Details
11.5.2 PRA Health Sciences Business Overview
11.5.3 PRA Health Sciences CRO in Clinical Trials Introduction
11.5.4 PRA Health Sciences Revenue in CRO in Clinical Trials Business (2016-2021)
11.5.5 PRA Health Sciences Recent Development
11.6 PPD
11.6.1 PPD Company Details
11.6.2 PPD Business Overview
11.6.3 PPD CRO in Clinical Trials Introduction
11.6.4 PPD Revenue in CRO in Clinical Trials Business (2016-2021)
11.6.5 PPD Recent Development
11.7 Charles River
11.7.1 Charles River Company Details
11.7.2 Charles River Business Overview
11.7.3 Charles River CRO in Clinical Trials Introduction
11.7.4 Charles River Revenue in CRO in Clinical Trials Business (2016-2021)
11.7.5 Charles River Recent Development
11.8 ICON
11.8.1 ICON Company Details
11.8.2 ICON Business Overview
11.8.3 ICON CRO in Clinical Trials Introduction
11.8.4 ICON Revenue in CRO in Clinical Trials Business (2016-2021)
11.8.5 ICON Recent Development
11.9 Wuxi AppTec
11.9.1 Wuxi AppTec Company Details
11.9.2 Wuxi AppTec Business Overview
11.9.3 Wuxi AppTec CRO in Clinical Trials Introduction
11.9.4 Wuxi AppTec Revenue in CRO in Clinical Trials Business (2016-2021)
11.9.5 Wuxi AppTec Recent Development
11.10 MedPace
11.10.1 MedPace Company Details
11.10.2 MedPace Business Overview
11.10.3 MedPace CRO in Clinical Trials Introduction
11.10.4 MedPace Revenue in CRO in Clinical Trials Business (2016-2021)
11.10.5 MedPace Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global CRO in Clinical Trials Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Phase I Trial
Table 3. Key Players of Phase II Trial
Table 4. Key Players of Phase III Trial
Table 5. Key Players of Phase IV Trial
Table 6. Global CRO in Clinical Trials Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global CRO in Clinical Trials Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global CRO in Clinical Trials Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global CRO in Clinical Trials Market Share by Regions (2016-2021)
Table 10. Global CRO in Clinical Trials Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global CRO in Clinical Trials Market Share by Regions (2022-2027)
Table 12. CRO in Clinical Trials Market Trends
Table 13. CRO in Clinical Trials Market Drivers
Table 14. CRO in Clinical Trials Market Challenges
Table 15. CRO in Clinical Trials Market Restraints
Table 16. Global CRO in Clinical Trials Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global CRO in Clinical Trials Market Share by Players (2016-2021)
Table 18. Global Top CRO in Clinical Trials Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRO in Clinical Trials as of 2020)
Table 19. Ranking of Global Top CRO in Clinical Trials Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by CRO in Clinical Trials Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players CRO in Clinical Trials Product Solution and Service
Table 23. Date of Enter into CRO in Clinical Trials Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global CRO in Clinical Trials Market Size by Type (2016-2021) (US$ Million)
Table 26. Global CRO in Clinical Trials Revenue Market Share by Type (2016-2021)
Table 27. Global CRO in Clinical Trials Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global CRO in Clinical Trials Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global CRO in Clinical Trials Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global CRO in Clinical Trials Revenue Market Share by Application (2016-2021)
Table 31. Global CRO in Clinical Trials Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global CRO in Clinical Trials Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America CRO in Clinical Trials Market Size by Type (2016-2021) (US$ Million)
Table 34. North America CRO in Clinical Trials Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America CRO in Clinical Trials Market Size by Application (2016-2021) (US$ Million)
Table 36. North America CRO in Clinical Trials Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America CRO in Clinical Trials Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America CRO in Clinical Trials Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe CRO in Clinical Trials Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe CRO in Clinical Trials Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe CRO in Clinical Trials Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe CRO in Clinical Trials Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe CRO in Clinical Trials Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe CRO in Clinical Trials Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific CRO in Clinical Trials Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific CRO in Clinical Trials Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific CRO in Clinical Trials Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific CRO in Clinical Trials Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific CRO in Clinical Trials Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific CRO in Clinical Trials Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America CRO in Clinical Trials Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America CRO in Clinical Trials Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America CRO in Clinical Trials Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America CRO in Clinical Trials Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America CRO in Clinical Trials Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America CRO in Clinical Trials Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa CRO in Clinical Trials Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa CRO in Clinical Trials Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa CRO in Clinical Trials Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa CRO in Clinical Trials Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa CRO in Clinical Trials Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa CRO in Clinical Trials Market Size by Country (2022-2027) & (US$ Million)
Table 63. Covance (Lab. Corp.) Company Details
Table 64. Covance (Lab. Corp.) Business Overview
Table 65. Covance (Lab. Corp.) CRO in Clinical Trials Product
Table 66. Covance (Lab. Corp.) Revenue in CRO in Clinical Trials Business (2016-2021) & (US$ Million)
Table 67. Covance (Lab. Corp.) Recent Development
Table 68. QVIA Company Details
Table 69. QVIA Business Overview
Table 70. QVIA CRO in Clinical Trials Product
Table 71. QVIA Revenue in CRO in Clinical Trials Business (2016-2021) & (US$ Million)
Table 72. QVIA Recent Development
Table 73. Syneos Health Company Details
Table 74. Syneos Health Business Overview
Table 75. Syneos Health CRO in Clinical Trials Product
Table 76. Syneos Health Revenue in CRO in Clinical Trials Business (2016-2021) & (US$ Million)
Table 77. Syneos Health Recent Development
Table 78. Parexel Company Details
Table 79. Parexel Business Overview
Table 80. Parexel CRO in Clinical Trials Product
Table 81. Parexel Revenue in CRO in Clinical Trials Business (2016-2021) & (US$ Million)
Table 82. Parexel Recent Development
Table 83. PRA Health Sciences Company Details
Table 84. PRA Health Sciences Business Overview
Table 85. PRA Health Sciences CRO in Clinical Trials Product
Table 86. PRA Health Sciences Revenue in CRO in Clinical Trials Business (2016-2021) & (US$ Million)
Table 87. PRA Health Sciences Recent Development
Table 88. PPD Company Details
Table 89. PPD Business Overview
Table 90. PPD CRO in Clinical Trials Product
Table 91. PPD Revenue in CRO in Clinical Trials Business (2016-2021) & (US$ Million)
Table 92. PPD Recent Development
Table 93. Charles River Company Details
Table 94. Charles River Business Overview
Table 95. Charles River CRO in Clinical Trials Product
Table 96. Charles River Revenue in CRO in Clinical Trials Business (2016-2021) & (US$ Million)
Table 97. Charles River Recent Development
Table 98. ICON Company Details
Table 99. ICON Business Overview
Table 100. ICON Revenue in CRO in Clinical Trials Business (2016-2021) & (US$ Million)
Table 101. ICON Recent Development
Table 102. Wuxi AppTec Company Details
Table 103. Wuxi AppTec Business Overview
Table 104. Wuxi AppTec CRO in Clinical Trials Product
Table 105. Wuxi AppTec Revenue in CRO in Clinical Trials Business (2016-2021) & (US$ Million)
Table 106. Wuxi AppTec Recent Development
Table 107. MedPace Company Details
Table 108. MedPace Business Overview
Table 109. MedPace CRO in Clinical Trials Product
Table 110. MedPace Revenue in CRO in Clinical Trials Business (2016-2021) & (US$ Million)
Table 111. MedPace Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRO in Clinical Trials Market Share by Type: 2020 VS 2027
Figure 2. Phase I Trial Features
Figure 3. Phase II Trial Features
Figure 4. Phase III Trial Features
Figure 5. Phase IV Trial Features
Figure 6. Global CRO in Clinical Trials Market Share by Application: 2020 VS 2027
Figure 7. Pharmaceutical Case Studies
Figure 8. Bio-pharm Case Studies
Figure 9. CRO in Clinical Trials Report Years Considered
Figure 10. Global CRO in Clinical Trials Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global CRO in Clinical Trials Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global CRO in Clinical Trials Market Share by Regions: 2020 VS 2027
Figure 13. Global CRO in Clinical Trials Market Share by Regions (2022-2027)
Figure 14. Global CRO in Clinical Trials Market Share by Players in 2020
Figure 15. Global Top CRO in Clinical Trials Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRO in Clinical Trials as of 2020
Figure 16. The Top 10 and 5 Players Market Share by CRO in Clinical Trials Revenue in 2020
Figure 17. Global CRO in Clinical Trials Revenue Market Share by Type (2016-2021)
Figure 18. Global CRO in Clinical Trials Revenue Market Share by Type (2022-2027)
Figure 19. North America CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America CRO in Clinical Trials Market Share by Type (2016-2027)
Figure 21. North America CRO in Clinical Trials Market Share by Application (2016-2027)
Figure 22. North America CRO in Clinical Trials Market Share by Country (2016-2027)
Figure 23. United States CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe CRO in Clinical Trials Market Share by Type (2016-2027)
Figure 27. Europe CRO in Clinical Trials Market Share by Application (2016-2027)
Figure 28. Europe CRO in Clinical Trials Market Share by Country (2016-2027)
Figure 29. Germany CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific CRO in Clinical Trials Market Share by Type (2016-2027)
Figure 37. Asia-Pacific CRO in Clinical Trials Market Share by Application (2016-2027)
Figure 38. Asia-Pacific CRO in Clinical Trials Market Share by Region (2016-2027)
Figure 39. China CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America CRO in Clinical Trials Market Share by Type (2016-2027)
Figure 47. Latin America CRO in Clinical Trials Market Share by Application (2016-2027)
Figure 48. Latin America CRO in Clinical Trials Market Share by Country (2016-2027)
Figure 49. Mexico CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa CRO in Clinical Trials Market Share by Type (2016-2027)
Figure 53. Middle East & Africa CRO in Clinical Trials Market Share by Application (2016-2027)
Figure 54. Middle East & Africa CRO in Clinical Trials Market Share by Country (2016-2027)
Figure 55. Turkey CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE CRO in Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Covance (Lab. Corp.) Revenue Growth Rate in CRO in Clinical Trials Business (2016-2021)
Figure 59. QVIA Revenue Growth Rate in CRO in Clinical Trials Business (2016-2021)
Figure 60. Syneos Health Revenue Growth Rate in CRO in Clinical Trials Business (2016-2021)
Figure 61. Parexel Revenue Growth Rate in CRO in Clinical Trials Business (2016-2021)
Figure 62. PRA Health Sciences Revenue Growth Rate in CRO in Clinical Trials Business (2016-2021)
Figure 63. PPD Revenue Growth Rate in CRO in Clinical Trials Business (2016-2021)
Figure 64. Charles River Revenue Growth Rate in CRO in Clinical Trials Business (2016-2021)
Figure 65. ICON Revenue Growth Rate in CRO in Clinical Trials Business (2016-2021)
Figure 66. Wuxi AppTec Revenue Growth Rate in CRO in Clinical Trials Business (2016-2021)
Figure 67. MedPace Revenue Growth Rate in CRO in Clinical Trials Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed